• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » MedCity News Q&A: Case Western’s Dr. Pablo Ros

MedCity News Q&A: Case Western’s Dr. Pablo Ros

June 17, 2010 By MedCity News

MedCity News logo

By Mary Vanac

The recently announced Philips Healthcare Global Advanced Imaging Innovation Center could bolster Northeast Ohio’s reputation as a hub for innovation in medical imaging technology.

But it also could do a lot for the research and clinical radiology practices at University Hospitals Case Medical Center, where the center will be housed.

The $38.4 million partnership of Philips, University Hospitals and Case Western Reserve University (CWRU) ’ supported by a $5 million Ohio Third Frontier grant ’ was announced a few weeks ago.

Philips (NYSE:PHG) — a Dutch company and a global imaging technology leader that employs more than 1,100 people at its worldwide computed tomography and nuclear medicine headquarters in the Cleveland suburb of Highland Heights — would test-drive its latest imaging technologies at the innovation center.

UH Case Medical Center would provide patients from its neurology, cardiology, pathology and oncology departments, as well as doctors and researchers, to kick the tires of the Philips technologies. Case Western Reserve engineers also would help evaluate the technologies.

Dr. Pablo Ros, radiology professor and chairman at the CWRU Radiology Department, and co-director of the Case Center for Imaging Research, will lead the new center. Ros is an academic heavy-hitter who arrived at the Cleveland university a year ago from Harvard University’s Brigham and Women’s Hospital. There, he was executive vice chairman of radiology. He also was chief of the radiology division at the Dana-Farber Cancer Institute in Boston.

MedCity News talked with Ros about the promise the new center holds for UH Case Medical Center professionals and patients.

MedCity News: What opportunities does the imaging innovation center offer professionals at UH Case Medical Center?

Pablo Ros: It will allow us to partner with engineers of Philips to translate our ideas into reality.

It’s something I have seen in a couple of other locations where there is a major industry player in the same vicinity as a major medical center. At Case, we also have a major engineering school and biomedical engineering department. And the University Hospitals system offers opportunities to deploy imaging equipment to help patients in facilities ranging from a large medical center to a small community hospital or out-patient health center.

But we don’t have the engineers. So if I have an idea for how to improve an imaging device, we have to contact the manufacturer and engage in long, complicated discussions. The center offers us a place to meet, a place to collaborate, to get things done quickly. It also offers prototype and pre-release technologies that we will work to improve.

MedCity News: What does the center mean to your medical students and residents, as well as patients?

PR: Having access to equipment and prototypes that would take years to reach mainstream medical facilities will be good for our students and residents. A component of the center is an international program for imaging education. So we are planning to have physicians from all over the world come and learn here. For our patients, it means we might be first in the world with a new technique or a new technology that would not otherwise be available.

MedCity News: Philips is investing $33.4 million in the first phase of the center where it will give researchers and clinicians the opportunity to use and evaluate its latest technologies. What does Philips get out of the deal?

PR: Imaging technology companies have no patients and no doctors to evaluate its products. Philips also likes the idea of working with a large American university and health system as a partner in innovation. The company had suitors from other countries for the innovation center — Israel, the Netherlands and China — and they selected us.

MedCity News: What are some of the lines of research you would like to see advanced at the center?

PR: We are grateful to have CT scanning, which uses x-rays, but we also realize the potential risks of ionic radiation. There is a tremendous movement in which we will participate to do more with less radiation. Some prototype technologies can reduce the amount of radiation exposure from standard equipment up to 90 percent — and with similar image quality.

MedCity News: Do you see future imaging innovations that don’t use radiation?

PR: Many. We will use more optical imaging, something called optical coherence tomography, and images produced from bioluminescence, borrowing pigments from fireflies and jellyfish.

MedCity News: What are the areas of medicine at UH Case Medical Center that might benefit from most from the imaging innovation center?

PR: Oncologic sciences would be a clear beneficiary. Also, imaging for cardiovascular diseases. And neurosciences. These are the three major beneficiaries. But there are also benefits for orthopedic to gastrointestinal diseases and others.

With an aging population, there are more and more degenerative diseases in which joints or organs or muscles lose function. The easiest way to monitor treatment is to look inside with images.

Another area that is growing is image-guided minimally invasive therapies. Instead of having to open the patient, you use an imaging probe and needles through the skin.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Philips

In case you missed it

  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy
  • NuVasive chief commercial officer Massimo Calafiore is stepping down
  • Preparing your medical device company for challenging market conditions
  • Dentsply Sirona replaces chief accounting officer amid internal investigation
  • Haemonetics stock rises on Street-beating Q1, raised guidance
  • Surgalign settles on OEM business sale, posts Q2 earnings miss
  • Alcon lowers its 2022 forecast amid strong dollar
  • Masimo beats Street in Q2 as healthcare business catches up
  • Senseonics stock is up as it sticks by revenue guidance
  • Butterfly Network asks judge to dismiss Fujifilm Sonosite IP suit
  • Stereotaxis stock down amid cloudy outlook
  • BD, Labcorp collaborate on flow cytometry-based diagnostics
  • NeuroOne submits special FDA 510(k) application for Evo sEEG electrode

RSS From Medical Design & Outsourcing

  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy